Hoth Therapeutics (NASDAQ:HOTH) shares rose by a staggering 215% today following significant breakthrough in cancer treatment. Their Phase 2a clinical trial of Hoth's topical gel HT-001 has shown 100% ...

Patients will be able to enroll in trial at any time and regardless of failure from other therapeutics This is a randomized, double-blind, placebo-controlled, multi-center Phase 2a dose-ranging study ...

Let’s take a look at video games’ favorite scene from the Star Wars series: the battle of Hoth. Developers have been trying for over 30 years to get it right. Which is your favorite? (This post was ...

NEW YORK, March 26, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced the deployment of OpenClaw™, an advanced AI-enabled ...

NEW YORK, June 18, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on breakthrough therapies, today announced that it has regained full ...

After announcing its mRNA therapy is effective against aggressive cancer cells, HOTH stock surged over 160%. Yet, since the news, Hoth Therapeutics (Nasdaq: HOTH) is again trending in the wrong ...

There isn't a more iconic battle in all of Star Wars than the fight for the planet Hoth in Episode V: The Empire Strikes Back. You could try to argue for other battles throughout the film franchise — ...